Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department?

Trial Profile

Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department?

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2015

At a glance

  • Drugs Methylnaltrexone bromide (Primary)
  • Indications Colonic disorders; Constipation
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 02 Apr 2015 Status changed from withdrawn prior to enrolment to discontinued, according to ClinicalTrials.gov record.
    • 14 Jan 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top